A compensação da dosagem gênica entre fêmeas XX e machos XY em mamíferos é adquirida através de um complexo mecanismo epigenético que resulta na inativação de grande parte de um dos cromossomos X nas células femininas. O processo de inativação do cromossomo X (XCI) se inicia cedo durante a embriogênese, concomitantemente à diferenciação celular, e envolve a aquisição de modificações epigenéticas características do cromossomo X inativo (Xi). Uma estabelecido, o padrão de inativação é estavelmente mantido através de todas as mitoses celulares subsequentes e por toda a vida do organismo (exceto para células germinativas que sofrem reativação do Xi). Os mecanismos envolvidos na iniciação e estabelecimento da XCI foram extensivamente estudados, especialmente em camundongos. Embora algumas características epigenéticas associadas à manutenção da XCI tenham sido descritas, a identidade e modo específico de ação de fatores envolvidos durante essa fase da XCI são aspectos ainda não bem compreendidos. Além disso, o processo de XCI apresenta diferenças importantes entre humanos e camundongos e estudos direcionados para a identificação de novos componentes envolvidos na manutenção da XCI em humanos tornam-se de fundamental importância. Triagens funcionais genômicas por bibliotecas de shRNAs constituem uma ferramenta poderosa para a identificação de genes envolvidos em diferentes mecanismos celulares e vias bioquímicas. Sendo assim, utilizamos essa ferramenta para triar genes envolvidos na manutenção da XCI em humanos. Células somáticas femininas primárias HPRT+/-/HPRT- foram transduzidas com uma biblioteca lentiviral de shRNAs e posteriormente tratadas em meio de cultura contendo a droga HAT para seleção de células HPRT+ nas quais esperava-se que o cromossomo Xi presente tivesse sofrido reativação em decorrência do knockdown de genes envolvidos na manutenção da XCI. Essa estratégia nos permitiu identificar 20 novos genes candidatos a estarem envolvidos na manutenção da XCI. Esses candidatos deverão ser avaliados individualmente para confirmar seu papel no processo de controle epigenético do cromossomo X / Transcriptional dosage compensation between mammalian XX females and XY males is acquired through a complex epigenetic mechanism that leads to the inactivation of most part of one of the X chromosomes in the female cells. The X chromosome inactivation (XCI) process takes place early during embryogenesis and involves the acquisition of epigenetic modifications that are characteristic of the inactive X chromosome (Xi). Once silencing is established, the inactivation pattern is maintained in through all the subsequent mitosis and the same X chromosome remains stably silenced in all the descendant cells and throughout the life of the organism (except for the germ line cells that undergo X chromosome reactivation). The initiation of XCI has been studied extensively, especially in mice. Although some epigenetic features associated with the maintenance of XCI have already been described, the identity and specific mode of action of the factors involved in this phase of XCI are largely unknown. Moreover, the XCI process presents important differences between mice and humans, and studies directed to the identification of new players involved in the maintenance of human XCI are fundamentally important. Functional genome-wide screens using multiplex shRNA libraries are a powerful tool for the identification of genes involved in different cellular mechanisms and biochemical pathways. In order to screen for genes involved in the maintenance of XCI in humans, a population of HPRT+/-/HPRT- primary somatic female cells were transduced with a multiplex lentiviral shRNA library and subsequently treated in HAT medium to select for HPRT+ cells in which we expected that the Xi would undergo reactivation as a result of the knockdown of genes involved in the maintenance of XCI. As a result, we identified 20 new candidate genes that could potentially be involved in the maintenance of XCI. These candidates should be individually evaluated in order to confirm their role in the epigenetic control of the X chromosome

Einige biologische Prozesse sind dosisabhängig, wobei nicht nur die Anwesenheit oder Abwesenheit bestimmter Genprodukte, sondern auch deren spezifische Mengen wichtig sind. Ein Beispiel ist die Dosis-Kompensation für Geschlechtschromosomen bei Säugetieren, die durch X-Chromosomen-Inaktivierung erreicht wird. Dieser Mechanismus ist auf Frauen beschränkt, da sie zwei X-Chromosomen besitzen, im Gegensatz zu Männern mit nur einem X-Chromosom. Dosisabhängigkeit spielt auch bei der Differenzierung pluripotenter Stammzellen eine Rolle. Geringe Schwankungen in der Menge des Pluripotenzfaktors OCT4 (POU5F1) können bestimmen, ob Maus-Embryonale Stammzellen (mESCs) sich in das Trophektoderm oder in meso-endodermale Linien differenzieren. Ebenso ist die Menge des Pluripotenzfaktors NANOG entscheidend für die Steuerung der naiven und vorbereiteten pluripotenten Zustände. Das Verständnis der dosisabhängigen Regulation biologischer Prozesse ist entscheidend, jedoch technisch anspruchsvoll, da es erfordert, die Proteinmenge quantitativ zu modulieren. Hier wurde ein auf Degron- und CRISPR/Cas-basiertes Toolkit, CasTuner, entwickelt, um die endogene Genexpression analog zu steuern. CasTuner basiert auf Cas-abgeleiteten Repressoren, die an eine Degron-Domäne fusioniert sind und durch die Titration der Konzentration eines Liganden gesteuert werden können. CasTuner ermöglicht eine homogene (analoge) Steuerung der Genexpression, im Gegensatz zum KRAB-basierten CRISPRi-System, das eine bimodale (digitale) Repression zeigt. Mit CasTuner wurden die Dosis-Wirkungs-Beziehungen von NANOG und OCT4 mit ihren Zielgenen und dem zellulären Phänotyp gemessen. Schließlich wurde CasTuner eingesetzt, um die dosisabhängige Rolle des X-gebundenen Xist-Aktivators RNF12 und des neu entdeckten Faktors ZIC3 zu untersuchen. Dabei wurde ein modifiziertes Modell für die zufällige X-Chromosomen-Inaktivierung vorgeschlagen. / Certain biological processes are dose-dependent, depending not only on the presence or absence of given gene products but also on their specific. The importance of quantitative regulation of gene expression is illustrated by the need for dosage compensation for sex chromosomes and by the presence of genes whose decreased expression is linked to diseases. The mechanism by which mammals achieve X-dosage compensation, X-chromosome inactivation, is itself dose-dependent, being restricted to females through sensing the two-fold higher dose for X-linked genes in females compared to males. Dose-dependency has been described in the differentiation of pluripotent stem cells into different lineages: small variations in the quantity of the pluripotency factor OCT4 (POU5F1) can determine the differentiation of mouse embryonic stem cells (mESCs) into the trophectoderm or meso-endoderm lineages. Similarly, the amount of the pluripotency factor NANOG is critical for the control of naïve and primed pluripotent states. Understanding the principles underlying the dose-dependent regulation of biological processes is crucial, but also technically challenging, since it requires the ability to quantitatively modulate protein abundance. Here, I developed a degron- and CRISPR/Cas-based toolkit, CasTuner, for analogue tuning of endogenous gene expression. CasTuner relies on Cas-derived repressors fused to a degron domain, which can be tuned by titrating the concentration of a ligand. I demonstrate homogenous (analogue) tuning of gene expression across cells, as opposed to the KRAB-based CRISPRi system, which exhibits bimodal (digital) repression. I employ CasTuner to measure the dose-response relationships of NANOG and OCT4 with their target genes and the cellular phenotype. Finally, I apply CasTuner to study the dose-dependent role of the X-linked Xist activator RNF12 and the newly discovered factor ZIC3, and propose a modified model for random X-chromosome inactivation.

Charles University in Prague Faculty of Science Ph.D. study program: Molecular and Cellular Biology, Genetics and Virology Abstract Genetics and genomics of hybrid sterility Mgr. Tanmoy Bhattacharyya Supervisor: Prof. MUDr. Jiří Forejt, DrSc. Praha 2013 Abstract Male-limited hybrid sterility restricts gene flow between the related species, an important pre- requisite of speciation. The F1 hybrid males of PWD/Ph female (Mus m. musculus subspecies) and C57BL/6J or B6 male (Mus m. domesticus) are azoospermic and sterile (PB6F1), while the hybrids from the reciprocal (B6PF1) cross are semi fertile. A disproportionately large effect of the X chromosome (Chr) on hybrid male sterility is a widespread phenomenon accompanying the origin of new species. In the present study, we mapped two phenotypically distinct hybrid sterility loci Hstx1 and Hstx2 to a common 4.7 Mb region on Chr. X. Analysis of meiotic prophase I of PB6F1 sterile males revealed meiotic block at mid-late pachynema and the TUNEL assay showed apoptosis of arrested spermatocytes. In sterile males over 95% of pachytene spermatocytes showed one or more unsynapsed autosomes visualized by anti SYCP1, HORMAD2 and SYCP3 antibodies. The phosphorylated form of H2AFX histone, normally restricted only to XY chromosome containing sex body decorated unsynapsed...

Human autopsy or biopsy tissue samples, mouse models and cell cultures of various types represent the most common materials in the investigation of cell pathogenesis of inherited diseases. This dissertation is devoted to all these approaches in the study of two X-linked lysosomal storage diseases, Fabry disease (FD,α-galactosidase A (AGAL) deficiency) and mucopolysaccharidosis type II (MPSII, idunorate-2- sulfatase (IDS) deficiency). The primary goal of the work was analysis of lipid blood group B antigens with terminal α-galactose (B-GSL) in the pancreas of FD patients with blood group B (FD-B).,In addition to the main glycosphingolipid (GSL) substrate, globotriaosylceramide (Gb3Cer), B-GSLs represent another minor substrate of AGAL. The deposition of undegraded B-GSL has been demonstrated in FD-B pancreas where it was significantly higher than in other organs such as the kidneys and lungs which accumulate mainly Gb3Cer. High concentration of lipid and non-lipid B-antigens was primarily confirmed in exocrine acinar epithelial cells of FD-B, accompanied by massive accumulation of ceroid (secondary sign of lysosomal storage). Unlike acini, the endocrine portion of the pancreas remained unaffected by accumulation of AGAL substrates. This interesting phenomenon of cell biology shows how a specific...

Comme dans la plupart des maladies auto-immunes une prédominance féminine est observée dans la polyarthrite rhumatoïde (PR). Le chromosome X, présent en 2 exemplaires chez la femme, est intéressant puisque beaucoup de gènes à fonctions immunitaires y sont localisés. Dans ce travail, nous montrons que certains de ces gènes peuvent augmenter leur nombre de copies quand l'individu vieillit. En outre, cette variation est spécifique au sexe avec une augmentation chez les hommes et l'inverse chez les femmes. D’autre part, alors que généralement les femmes inactivent aléatoirement (50:50) le chromosome X d’origine maternel ou X d’origine paternel, nous montrons un biais d’inactivation (≥ 80:20) chez les femmes atteintes de PR. De plus ce biais est préférentiellement associé à celles qui portent les gènes de susceptibilité à la maladie. Ces résultats soulignent l’importance du chromosome X dans le développement de l’auto-immunité et aident à la compréhension du biais féminin dans ces maladies. / As in many autoimmune diseases, a female predominance is observed in rheumatoid arthritis (RA). The X chromosome, present in 2 copies in females, is of particular interest as it contains many genes with immune functions. In this work, we show an increase with age in copy number of some X-linked genes in peripheral blood cells of men, healthy or with RA. Importantly, this increase is not observed in women. On the other hand, when in fact females generally randomly inactivate (50:50) either the paternally-derived or the maternally-derived X chromosome, we show a skewed inactivation (≥ 80:20) in women with RA. Moreover this skewing correlates preferentially with women carrying disease susceptibility genes. Altogether, our findings highlight the importance of this fascinating chromosome in the development of autoimmunity in a step forward to better understand female predilection to autoimmune diseases.

Theory predicts that sexually antagonistic mutations will be over- or under-represented on the X and Z chromosomes, depending on the average dominance coefficient of the mutations. However, as little is known about the dominance coefficients for new mutations, the effect of sexually antagonistic selection is difficult to predict. To elucidate the role of sexually antagonistic selection in the evolution of Z chromosome gene content in chicken, we analyzed publicly available microarray data from several somatic tissues as well as somatic and germ cells of the ovary. We found that the Z chromosome is enriched for genes showing preferential expression in ovarian somatic cells, but not for genes with preferential expression in primary oocytes or non-sex-specific somatic tissues. Our results suggest that sexual antagonism leads to higher abundance of female-benefit alleles on the Z chromosome. No bias towards Z-linkage of oocyte-enriched genes can be explained by lower intensity of sexually antagonistic selection in ovarian germ cells compared to ovarian somatic cells. An alternative explanation would be that meiotic Z chromosome inactivation hinders accumulation of oocyte-expressed genes on the Z chromosome. Our results are consistent with findings in mammals and indicate that recessive rather than dominant...

Les cellules souches hématopoïétiques (CSH) assurent une production constante des cellules sanguines tout au long de la vie, mais sont vulnérables à l’acquisition de mutations pouvant mener à une transformation maligne. Les mutations qui confèrent un avantage de croissance entraîneront une prolifération clonale. L’étude de la clonalité est centrale à la compréhension de ces phénomènes. Historiquement, l’analyse de la clonalité a été possible grâce au principe de l’inactivation du chromosome X (ICX) chez les femmes qui entraîne la création de deux populations cellulaires, celle avec le X-paternel actif et celle avec le X-maternel actif. Une déviation (biais) de la proportion théorique de 1 :1 entre ces deux populations peut supposer une dominance clonale. Nous avons démontré un biais significatif de l’ICX chez les femmes avec l’âge. Ce phénomène peut être expliqué par plusieurs causes dont la sélection hémizygote (un des deux X possède des allèles plus forts que l’autre) et l’acquisition de mutations dans une CSH. Nous posons l’hypothèse que ces deux phénomènes coexistent et peuvent être distingués par une approche génomique. Nous avons recruté une cohorte de 2996 femmes canadiennes-françaises âgées entre 37 et 101 ans composée de 2172 individus issus de 321 familles et de 824 individus non apparentés. Deux tissus biologiques ont été recueillis : le sang périphérique (PMN, monocytes, lymphocytes T, lymphocytes B) et des cellules buccales. Le ratio de l’ICX a été déterminé par la méthode HUMARA, l’analyse de gènes associés à l’hématopoïèse clonale (19 gènes) a été faite par la méthode de séquençage NGS, et la cohorte a été génotypée à 700 625 loci polymorphiques de l’ADN (SNP). Des analyses bioinformatiques ont été - iv - appliquées pour étudier la contribution génétique au biais de l’ICX. Nous démontrons que : (i) le biais de l’ICX est plus prévalent dans les cellules sanguines par rapport aux cellules épithéliales et maximal dans les cellules myéloïdes; (ii) le biais augmente avec l’âge seulement dans les cellules sanguines et que cette influence est plus marquée pour les neutrophiles; (iii) la concordance du biais est très importante pour les différents types cellulaires sanguins, suggérant un mécanisme opérant au niveau de la CSH ; (iv) il y a une composante héréditaire liée au biais de l’ICX; (v) la présence de mutations acquises (TET2, DNMT3A, etc.) explique seulement une partie du biais ; (vi) à l’aide d’analyses par liaison génétique la présence d’une région sur le chromosome X à Xq21 (LOD score 4.9) qui est associée au biais des lymphocytes T et une autre sur le chromosome 1 à 1q21 (LOD score 6) qui est associée au biais des neutrophiles. Nous avons départagé la contribution liée à l’acquisition de mutations somatiques et identifié pour la première fois des régions liées à une prédisposition génétique. Nos travaux se poursuivront d’une part par l’analyse de gènes candidats dans les régions identifiées, et d’autre part nous tenterons d’identifier les cibles génétiques qui confèrent un potentiel de transformation maligne en utilisant une approche basée sur l’analyse du méthylome, de l’hydroxyméthylome et du transcriptome que nous venons de valider. Notre étude démontre la complexité de l’adaptation de l’hématopoïèse au vieillissement et ouvre des portes sur l’identification de facteurs prédisposant aux cancers hématologiques. / Hematopoietic stem cells (HSC) ensure a constant lifelong production of blood cells, but are vulnerable to acquisition of mutations, which may lead to malignant transformation. Mutations that confer a growth advantage will lead to clonal derivation of cells. The study of clonality is central to the understanding of hematopoiesis adaptation to aging. Historically, the first clonality assays were based on the principle of X-chromosome inactivation (XCI) in women. Women are mosaics with half the cells with the paternal X active and the other half with the maternal one. A skewing from the theoretical 1:1 ratio between these two populations of cells could infer clonal derivation of cells. More than 20 years ago, our team demonstrated, through analysis of (XCI) in women, that skewing increases with age. This intriguing phenomenon can be explained by several etiology including hemizygous selection (one of the 2 Xs has stronger alleles) or the acquisition of mutations giving a growth advantage. The first etiology is genetically predetermined and the second, acquired in somatic cells of bone marrow. We hypothesize that these two phenomena coexist and can be distinguished with a genomic approach. To test our hypothesis, we investigated skewing in a cohort of 2996 French-Canadian women aged 37 to 101 comprised of 2172 related individuals from 321 families and 824 unrelated individuals. We analyzed XCI ratios at the HUMARA locus in epithelial cells, neutrophils, T-cells, monocytes, B-lymphocytes. We genotyped the cohort for clonal hematopoiesis and looked for germline heritable components by genome wide association studies and linkage analyses. We document that skewing was more prevalent in blood cells than in epithelial cells, and maximal in myeloid cells. Skewing increases with age only in blood cells. Intra- vi - individual correlation of skewing blood cell types was strongly correlated, suggesting selection influences operating at the HSC. Sibship analyses demonstrated heritability which was strongest when parental origin of skewing was taken into account. Clonal hematopoiesis accounted only for a small proportion of the skewing trait but its importance increased in the very old. Linkage analysis identified a region at Xq21 for skewing occurring in T-cells (LOD score 4.9) suggesting a hemizygous cell selection influence. We also identified a region at 1q21 for skewing in neutrophils (LOD score 6) suggesting a gene-gene interaction with Xlinked genes. We have demonstrated that age-associated skewing is a complex trait caused in part by acquired mutations and genetic predisposition variants. We will pursue our investigation using a candidate gene approach in the two identified regions and will try to identify genetic targets of oncogenic potential by a method based on analysis of the methylome, hydroxymethylome and transcriptome that was have validated in this cohort. This thesis demonstrates the complexity of the adaptation mechanisms of hematopoiesis to aging and set the stage to identification of factors predisposing to hematological cancers.

Inherited metabolic disorders (IMD) form a diverse group of several hundred different diseases with a relatively high cumulative incidence (stated up to 1:600). They are associated with accumulation of the substrates and lack of the products in specific metabolic pathways, which is caused by deficiency of the enzyme or its activator, or dysfunction of the transport protein. However, the underlying cause is at the DNA level. The grounds for different phenotype manifestation in patients with the same genotype are often not known. During my work at the Institute of Inherited Metabolic Disorders, I designed several new methods for the research of IMD and applied them in the patients and their families. I created procedures for the isolation of lysosomal membranes that are used for the research of lysosomal storage disorders and general properties of lysosomes. Next, I introduced several novel assays for determination of the X-inactivation ratio, which led to a significant increase of informative women. Nowadays, we use these methods in heterozygous women with X-linked diseases in order to study the influence of X-inactivation on the manifestation of the diseases. The cases of a girl with mucopolysaccharidosis type II, a girl with OTC deficiency and a family with the mutation in HPRT1 gene are described...

La régulation de l’expression génique chez les mammifères dépend de l’organisation tridimensionnelle des chromosomes, en particulier à l’échelle des communications entre les séquences régulatrices et leurs promoteurs cibles. Ainsi, les chromosomes sont organisés en une nouvelle architecture consistant en domaines d’interactions topologiques (TADs, acronyme anglais). Mon projet de thèse avait pour but de caractériser les mécanismes moléculaires impliqués dans cette architecture et leurs importances au cours du développement embryonnaire, pour un locus bien particulier, le Xic (acronyme anglais pour X-inactivation centre). Le Xic contient les éléments régulateurs nécessaires pour initier l’inactivation du chromosome X (ICX), un phénomène épigénétique spécifique du développement des mammifères femelles, rendant l’un des deux chromosomes X inactif du point de vue transcriptionnelle. L’ICX permet d’égaliser l’expression des gènes liés au X entre les sexes chez les mammifères. Le Xic est organisé au moins en deux TADs mais une partie du locus reste encore non identifiée. Je présente ici une analyse fonctionnelle approfondie des différents éléments régulateurs au sein du Xic, comprenant des enhancers, des gènes d’ARNs non codants et des éléments structurels. Après avoir créé une série d’allèles mutés chez la souris et les cellules souches embryonnaires murines, j’ai caractérisé l’impact de ces réarrangements génomiques sur le paysage structurel et transcriptionnel du Xic. J’ai identifié des nouveaux acteurs dans la régulation de ce locus, en particulier des séquences régulatrices conservées chez les mammifères placentaires et des éléments structurels importants pour la formation d’une frontière entre les deux TADs du Xic, importante pour leur séparation et régulation. Je décris aussi la découverte de communication entre ces TADs, ce qui constitue un mécanisme inédit de régulation génique pendant le développement. Ce travail contribue à un nouveau niveau de compréhension des lois qui régissent l’organisation des TADs dans le contexte de la régulation génique chez les mammifères. / Mammalian gene regulatory landscapes rely on the folding of chromosomes in the recently discovered topologically associating domains (TADs), which ensure appropriate communication between cis-regulatory elements and their target promoters. The aim of my PhD project was to characterise the molecular mechanisms that govern this novel architecture and its functional importance in the context of a critical and developmentally regulated locus, the X-inactivation centre (Xic). The Xic contains the necessary elements to trigger X-chromosome inactivation, an epigenetic phenomenon that occurs during the development of female mammals to transcriptionally silence one of the X-chromosomes and equalise X-linked gene expression between sexes. The Xic is partitioned into at least two TADs, but its full extent is unknown. Here, I present a comprehensive functional analysis of different cis-regulatory elements within the Xic, including enhancer-like regions, long noncoding RNA loci and structural elements. Upon generating a series of mutant alleles in mice and murine embryonic stem cells, I characterised the impact of these genomic rearrangements in the structural and transcriptional landscape of the Xic and identified novel players in the regulation of this locus, including cis-acting elements conserved across placental mammals and structural elements critical for the insulation between the Xic TADs. I also found evidence for communication across TADs at this locus, which provides new insights into how regulatory landscapes can work during development. This study also extends our understanding of the rules governing the organisation of TADs and their chromatin loops in the context of mammalian gene regulation. / Nos mamíferos, a regulação da expressão genética depende da organização tridimensional dos cromosomas, em particular ao nível da comunicação regulatória entre promotores e enhancers. A esta escala, descobriu-se recentemente que os cromossomas estão organizados em domínios de interações topológicas (conhecidos como TADs, no acrónimo inglês) que se pensa providenciarem uma base estrutural para as paisagens de regulação transcricional dos genes. O meu projecto de tese teve como objectivo caracterizar os mecanismos moleculares responsáveis por esta arquitectura e a sua importância funcional no contexto de um locus crítico para o desenvolvimento embrionário, o centro de inactivação do cromossoma X (Xic, acrónimo inglês). O Xic contém os elementos genéticos necessários e suficientes para iniciar a inactivação do cromossoma X, um fenómeno epigenético que ocorre durante o desenvolvimento das fêmeas de mamíferos para silenciar um dos cromosomas X e igualar a expressão dos genes do X entre indivíduos XX e XY. O Xic está organizado em pelo menos dois TADs, mas o seu intervalo genético completo permanece desconhecido. Apresento nesta tese uma análise funcional e detalhada de diferentes sequências reguladoras presentes no Xic, incluindo regiões do tipo enhancer, genes de ARNs não codificantes e elementos estruturais. Após a criação de diversos alelos mutantes (deleções, inserções, inversões) em ratinho e em células estaminais embrionárias, através das recentes técnicas de engenharia genética, TALENs e CRISPR/Cas9, caracterizei o impacto destes rearranjos genéticos na paisagem topológica e transcricional do Xic, o que permitiu a identificação de novos actores moleculares na regulação deste locus. Em particular, descobrimos sequências de regulação transcricional altamente conservadas em mamíferos placentários e elementos estruturais importantes para a formação da fronteira entre os dois TADs do Xic. Descrevo também evidência de que há comunicação entre os dois TADs neste locus, o que compromete os modelos actuais do modus operandis dos TADs, e por isso contribui para um novo nível de compreensão dos mecanismos que regulam a expressão genética durante o desenvolvimento.

Inherited metabolic disorders (IMD) form a diverse group of several hundred different diseases with a relatively high cumulative incidence (stated up to 1:600). They are associated with accumulation of the substrates and lack of the products in specific metabolic pathways, which is caused by deficiency of the enzyme or its activator, or dysfunction of the transport protein. However, the underlying cause is at the DNA level. The grounds for different phenotype manifestation in patients with the same genotype are often not known. During my work at the Institute of Inherited Metabolic Disorders, I designed several new methods for the research of IMD and applied them in the patients and their families. I created procedures for the isolation of lysosomal membranes that are used for the research of lysosomal storage disorders and general properties of lysosomes. Next, I introduced several novel assays for determination of the X-inactivation ratio, which led to a significant increase of informative women. Nowadays, we use these methods in heterozygous women with X-linked diseases in order to study the influence of X-inactivation on the manifestation of the diseases. The cases of a girl with mucopolysaccharidosis type II, a girl with OTC deficiency and a family with the mutation in HPRT1 gene are described...